0001562180-16-002821.txt : 20160719
0001562180-16-002821.hdr.sgml : 20160719
20160719183408
ACCESSION NUMBER: 0001562180-16-002821
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160718
FILED AS OF DATE: 20160719
DATE AS OF CHANGE: 20160719
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intersect ENT, Inc.
CENTRAL INDEX KEY: 0001271214
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 200280837
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-641-2100
MAIL ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: SINEXUS INC
DATE OF NAME CHANGE: 20031124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stambaugh James
CENTRAL INDEX KEY: 0001614498
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36545
FILM NUMBER: 161774289
MAIL ADDRESS:
STREET 1: 1555 ADAMS DRIVE
STREET 2: C/O INTERSECT ENT, INC.
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2016-07-18
false
0001271214
Intersect ENT, Inc.
XENT
0001614498
Stambaugh James
C/O INTERSECT ENT, INC., 1555 ADAMS DR.
MENLO PARK
CA
94025
false
true
false
false
VP Clinical Affairs
Common Stock
2016-07-18
4
M
false
5000.00
0.48
A
29000.00
D
Common Stock
2016-07-18
4
S
false
5000.00
15.3286
D
24000.00
D
Stock Option (right to buy)
0.48
2016-07-18
4
M
false
3062.00
0.00
D
2016-11-16
Common Stock
3062.00
0.00
D
Stock Option (right to buy)
0.48
2016-07-18
4
M
false
1938.00
0.00
D
2017-08-21
Common Stock
1938.00
14693.00
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2016.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.27 to $15.39, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4.
The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option vest monthly over 48 months beginning October 23, 2007.
The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option vest monthly over 48 months beginning August 22, 2007.
/s/ Jeryl L. Hilleman, Attorney-in-Fact for James W. Stambaugh
2016-07-19